PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma

[1]  T. Yoshimine,et al.  PTEN Mutations in Malignant Gliomas and their Relation with Meningeal Gliomatosis , 2001, Journal of Neuro-Oncology.

[2]  Y. Okada,et al.  Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. , 2001, Journal of neurosurgery.

[3]  T. Yoshimoto,et al.  Functional evaluation of p53 and PTEN gene mutations in gliomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  C. James,et al.  Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  Erwin G. Van Meir,et al.  The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. , 1999, Cancer research.

[6]  G. Schackert,et al.  Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  Kenneth M. Yamada,et al.  PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1999, The Journal of Biological Chemistry.

[8]  Kenneth M. Yamada,et al.  Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor–mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways , 1998, The Journal of cell biology.

[9]  W. Yung,et al.  Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Kenneth M. Yamada,et al.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.

[11]  D. Louis,et al.  PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.

[12]  W. Isaacs,et al.  Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. , 1998, Cancer research.

[13]  J. Bruce,et al.  Somatic mutations of PTEN in glioblastoma multiforme. , 1997, Cancer research.

[14]  R. McLendon,et al.  PTEN gene mutations are seen in high-grade but not in low-grade gliomas. , 1997, Cancer research.

[15]  P. Guldberg,et al.  Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. , 1997, Cancer research.

[16]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[17]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[18]  M. Emi,et al.  Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer , 1996, Genes, chromosomes & cancer.

[19]  H. Woo,et al.  Disseminated ependymomas of the central nervous system. , 1996, Journal of neurosurgery.

[20]  J. Thalabard,et al.  Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease. , 1994, British Journal of Cancer.

[21]  M. Berger,et al.  Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. , 1994, Journal of neurosurgery.

[22]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  R. Selker,et al.  Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. , 1990, Neurosurgery.

[24]  I. Awad,et al.  Leptomeningeal metastasis from supratentorial malignant gliomas. , 1986, Neurosurgery.

[25]  R. Packer,et al.  Leptomeningeal dissemination of primary central nervous system tumors of childhood , 1985, Annals of neurology.

[26]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[27]  W. Shapiro,et al.  Meningeal gliomatosis: A review of 12 cases , 1980, Annals of neurology.

[28]  R. Davis,et al.  Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme , 1978, Cancer.

[29]  P. Rubin,et al.  The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. , 1976, International journal of radiation oncology, biology, physics.

[30]  T. Kawase,et al.  Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas , 2006, Brain Tumor Pathology.

[31]  M. Taneda,et al.  Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome , 2005, Acta Neurochirurgica.

[32]  H. Singer,et al.  Cerebrospinal metastases in malignant childhood astrocytomas , 2004, Journal of Neuro-Oncology.

[33]  W. Yung,et al.  Advances in Brief Differential Expression of MMAC / PTEN in Glioblastoma Multiforme : Relationship to Localization and Prognosis 1 , 1999 .

[34]  S. Petersen,et al.  Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. , 1998, British Journal of Cancer.

[35]  A. L. Albright,et al.  Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. , 1992, Neurosurgery.